CALACalithera Biosciences, Inc.

0.0001USD0.00%Mkt Cap: 487 $P/E:

Calithera Biosciences, Inc. operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosc…

Key Statistics

Company
Market Cap487 $
Enterprise Value-1.44M $
Revenue (TTM)
Gross Profit-28.53M $
Net Income (TTM)-39.65M $
Revenue/Share
Last Price0.0001 USD
Fiscal Year EndDec 2022
MR QuarterDec 2022
Employees8
CountryUS
SectorHealthcare
IndustryShell Companies
ISIN
Valuation
P/E (Trailing)
P/E (Forward)-0.00
PEG
EV/EBITDA0.03
EV/Revenue
P/S
P/B-0.00
EPS (TTM)-1.32
EPS (Forward)-1.35
52W Range
0.00010% of range0.0010
52W High0.0010 USD
52W Low0.0001 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-194.44%
ROA-138.27%
Growth
Revenue Growth
Earnings Growth
Cash Flow & Leverage
Operating CF-43.61M $
CapEx (TTM)133.00K $
FCF Margin
FCF Yield-5785266.94%
Net Debt-23.79M $
Net Debt/EBITDA0.57
Balance Sheet
Debt/Equity0.08
Current Ratio3.60
Quick Ratio3.44
Book Value/Sh-0.4010 USD
Cash/Share5.223 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Splits
Last Split1:20
Split DateJun 15, 2022
Analyst Consensus
Rating
Target (Mean)
Target Range
# Analysts
Ownership
Shares Out.4.87M
Float4.83M
Insiders0.00%
Institutions0.00%
Short Interest
Short Ratio0.8d
Short % Float8.92%
Short % Out.8.57%
Shares Short417.28K
Short (prev mo.)148.51K
Technical
SMA 500.0003 (-61.2%)
SMA 2000.0003 (-63.5%)
Beta-1.22
S&P 52W Chg18.16%
Avg Vol (30d)106
Avg Vol (10d)15
Technical Indicators
RSI (14)28.3
MACD-0.0000
MACD Signal-0.0000
MACD Hist.-0.0000
BB Upper0.0004 USD
BB Middle0.0002 USD
BB Lower-0.0000 USD
BB Width205.20%
ATR (14)0.0000 USD
Vol Ratio (20d)0.00x